Obeid, K.; Kanellopoulos, P.; Abouzayed, A.; Mattsson, A.; Tolmachev, V.; Nock, B.A.; Maina, T.; Orlova, A.
GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics. Pharmaceutics 2024, 16, 513.
https://doi.org/10.3390/pharmaceutics16040513
AMA Style
Obeid K, Kanellopoulos P, Abouzayed A, Mattsson A, Tolmachev V, Nock BA, Maina T, Orlova A.
GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics. Pharmaceutics. 2024; 16(4):513.
https://doi.org/10.3390/pharmaceutics16040513
Chicago/Turabian Style
Obeid, Karim, Panagiotis Kanellopoulos, Ayman Abouzayed, Adam Mattsson, Vladimir Tolmachev, Berthold A. Nock, Theodosia Maina, and Anna Orlova.
2024. "GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics" Pharmaceutics 16, no. 4: 513.
https://doi.org/10.3390/pharmaceutics16040513
APA Style
Obeid, K., Kanellopoulos, P., Abouzayed, A., Mattsson, A., Tolmachev, V., Nock, B. A., Maina, T., & Orlova, A.
(2024). GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics. Pharmaceutics, 16(4), 513.
https://doi.org/10.3390/pharmaceutics16040513
